Carter Caldwell

Penn Medicine Co-Investment Program Director, University of Pennsylvania Health System

πŸ“ Philadelphia, Pennsylvania, United StatesπŸ”„ Updated September 2026πŸ’Ό 8 investmentsπŸ“… 16 years investingπŸ—“ Last invested Jan 2025
VC🌍 United States
8
Total investments
1
Early stage
1
Mid stage
0
Late stage
16y
Years active

Portfolio

6 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jan 2025
Dedicated to accelerating the use of cell-based therapies by manufacturing innovation, based in Philadelphia
Board Observer
Mar 2022
We believe communication is at the heart of delivering the highest quality care in today's complicated health care system with fragmented teams. We are taking tried and tested technologies from other high risk industries and applying them to health care with a "by clinicians for clinician"​ workflow that is used by thousands of front-line practitioners every day. CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care....AS A TEAM. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more. Teams stay in constant communication as each person can view and contribute to the task list from any electronic device, instead of relying on paper lists tucked away in one person's pocket.
Board Observer
Sep 2021
Vittoria Biotherapeutics is committed to unlocking the promise of cell therapies while addressing their inherent challenges by strengthening efficacy, improving safety, and broadening therapeutic applicability for patients with difficult-to-treat diseases. An Important Note About Privacy: Vittoria Biotherapeutics is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth, or bank account details via email, job recruiting, or social media platforms. We do not hire virtually or solicit/interview candidates on Indeed, Telegram, Wire, Google Hangouts or similar public platforms. Any questions about career opportunities can be directed to info@vittoriabio.com.
Board Observer
Mar 2020
Interius is a clinical stage biotechnology company, engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases.
Board Observer
Jun 2019
Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has more patient experience than any other cell therapy company. For more information about Kite, please visit www.kitepharma.com and follow Kite Pharma on LinkedIn for updates. Note: Comments on the Tmunity LinkedIn page are not actively monitored.
Board Member
2012
We are an Acquisition Marketing (TM) Agency. We develop and execute marketing programs across all digital and traditional platforms, driven by immediate and measurable response metrics. "Humanology" drives our success: Technology + Experienced Brainpower.
Experience Β· 10 entries
All (10)
Investments (8)
Founder (1)
Board (8)
2025
Board Observer
Jan 2025
Dedicated to accelerating the use of cell-based therapies by manufacturing innovation, based in Philadelphia
2022
Board Observer
Mar 2022
We believe communication is at the heart of delivering the highest quality care in today's complicated health care system with fragmented teams. We are taking tried and tested technologies from other high risk industries and applying them to health care with a "by clinicians for clinician"​ workflow that is used by thousands of front-line practitioners every day. CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care....AS A TEAM. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more. Teams stay in constant communication as each person can view and contribute to the task list from any electronic device, instead of relying on paper lists tucked away in one person's pocket.
2021
Board Observer
Sep 2021
Vittoria Biotherapeutics is committed to unlocking the promise of cell therapies while addressing their inherent challenges by strengthening efficacy, improving safety, and broadening therapeutic applicability for patients with difficult-to-treat diseases. An Important Note About Privacy: Vittoria Biotherapeutics is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth, or bank account details via email, job recruiting, or social media platforms. We do not hire virtually or solicit/interview candidates on Indeed, Telegram, Wire, Google Hangouts or similar public platforms. Any questions about career opportunities can be directed to info@vittoriabio.com.
2020
Board Observer
Mar 2020
Interius is a clinical stage biotechnology company, engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases.
2019
Board Observer
Jun 2019
Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has more patient experience than any other cell therapy company. For more information about Kite, please visit www.kitepharma.com and follow Kite Pharma on LinkedIn for updates. Note: Comments on the Tmunity LinkedIn page are not actively monitored.
Show all 10 entries ↓
Investment activity
2010–2025 Β· 8 investments
2010120121201712019120201202112022120251
Recent (last 2 years)Earlier